Publications Database

Jesner O. S. , Aref-Adib M. , Coren E. (2007)

Risperidone for autism spectrum disorder.

Cochrane Database of Systematic Reviews

(1), CD005040

Read Abstract (New Window) Read Full (New Window)

Kemner C. et al. (2002)

Open-label study of olanzapine in children with pervasive developmental disorder.

Journal of Clinical Psychopharmacology

22 pp. 455-460

Read Abstract (New Window)

King B. et al. (2003)

Use of risperidone in a paediatric population: an observational study.

Journal of Paediatrics and Child Health

39(7), pp. 523-527

Read Abstract (New Window)

Kirino E. (2014)

Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children.

Clinical Medicine Insights: Pediatrics

May, 8 pp. 17-30.

Read Abstract (New Window) Read Full (New Window)

Lemmon M. E. , Gregas M. , Jeste S. S. (2011)

Risperidone use in autism spectrum disorders: A retrospective review of a clinic-referred patient population.

Journal of Child Neurology

26(4), pp. 428-432

Read Abstract (New Window)

Luby J. et al. (2006)

Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 575-587

Read Abstract (New Window)

Malone R. P. et al. (2001)

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

Journal of the American Academy of Child and Adolescent Psychiatry

40 pp. 887-894.

Read Abstract (New Window)

Malone R. P. et al. (2002)

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.

Journal of the American Academy of Child and Adolescent Psychiatry

41(2), pp. 140-147

Read Abstract (New Window)

Mankoski R. et al. (2013)

Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.

Journal of Child and Adolescent Psychopharmacology

23(8), pp. 572-576.

Read Abstract (New Window)

Marshall J. et al. (2014)

Features of feeding difficulty in children with autism spectrum disorder.

International Journal of Speech-Language Pathology

April, 16(2), pp. 151-158.

Read Abstract (New Window)

Martin A. et al. (1992)

Open-label quetiapine in the treatment of children and adolescents with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

9(2), pp. 99-107

Read Abstract (New Window)

Martin A. et al. (2004)

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.

American Journal of Psychiatry

161(6), pp. 1125-1127

Read Abstract (New Window) Read Full (New Window)

Matson J. L. , Hess J. A. (2011)

Psychotropic drug efficacy and side effects for persons with autism spectrum disorders.

Research in Autism Spectrum Disorders

51

Read Abstract (New Window)

McCracken J. T. et al. (2002)

Risperidone in children with autism and serious behavioral problems.

New England Journal of Medicine

347(5), pp. 314-321

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. , Kem D. , Posey D. J. (2002)

Case series: use of ziprasidone for maladaptive symptoms in youths with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

41(8), pp. 921-927

Read Abstract (New Window)

Mouridsen S. E. , Rich B. , Isager T. (2008)

Body mass index in male and female children with pervasive developmental disorders.

Pediatrics International

50(4), pp. 569-571.

Read Abstract (New Window)

Mukaddes N. M. , Abali O. , Gurkan K. (2004)

Short-term efficacy and safety of risperidone in young children with autistic disorder (AD).

World Journal of Bilogical Psychiatry

5(4), pp. 211-214

Read Abstract (New Window)

Nagaraj R. , Singhi P. , Malhi P. (2006)

Risperidone in children with autism: randomized, placebo-controlled, double-blind study.

Journal of Child Neurology

21(6), pp. 450-455

Read Abstract (New Window)

Nicolson R. , Awad G. A. , Sloman L. (1998)

An open trial of risperidone in young autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

37(4), pp. 372-376

Read Abstract (New Window)

Potenza M. et al. (1999)

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

Journal of Clinical Psychopharmacology

19(1), pp. 37-4.

Read Abstract (New Window)